Skip Navigation


Human Molecular Genetics Advance Access originally published online on June 1, 2006
Human Molecular Genetics 2006 15(14):2192-2199; doi:10.1093/hmg/ddl144
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
15/14/2192    most recent
ddl144v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Yu, Y.
Right arrow Articles by Gelernter, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, Y.
Right arrow Articles by Gelernter, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Intronic variants in the dopa decarboxylase (DDC) gene are associated with smoking behavior in European-Americans and African-Americans

Yi Yu1, Carolien Panhuysen1,2, Henry R. Kranzler4, Victor Hesselbrock4, Bruce Rounsaville5, Roger Weiss7,8, Kathleen Brady9, Lindsay A. Farrer1,2,3 and Joel Gelernter5,6,*

1 Department of Medicine (Genetics Program), 2 Department of Biostatistics, 3 Department of Neurology, Genetics and Genomics and Epidemiology, Boston University Schools of Medicine and Public Health, Boston, MA, USA, 4 Departments of Psychiatry and Neurobiology, University of Connecticut Health Center, Farmington, CT, USA, 5 Department of Psychiatry, VA CT Healthcare Center and 6 Department of Neurobiology, Yale University School of Medicine, USA, 7 Alcohol and Drug Abuse Treatment Program, McLean Hospital, Belmont, MA, USA, 8 Department of Psychiatry, Harvard Medical School, Boston, MA, USA and 9 Department of Psychiatry, Medical University of South Carolina, Charleston, SC, USA

* To whom correspondence should be addressed at: Department of Psychiatry, Yale University School of Medicine, Division of Human Genetics in Psychiatry, VA CT 116A2, 950 Campbell Avenue, West Haven, CT 06516, USA. Fax: +1 2039373897; Email: joel.gelernter{at}yale.edu

Received March 23, 2006; Revised May 16, 2006; Accepted May 29, 2006

We report here a study considering association of alleles and haplotypes at the DOPA decarboxylase (DDC) locus with the DSM-IV diagnosis of nicotine dependence (ND) or a quantitative measure for ND using the Fagerstrom Test for Nicotine Dependence (FTND). We genotyped 18 single nucleotide polymorphisms (SNPs) spanning a region of ~210 kb that includes DDC and the genes immediately flanking DDC in 1590 individuals from 621 families of African-American (AA) or European-American (EA) ancestry. Evidence of association (family-based tests) was observed with several SNPs for both traits (0.0002≤P≤0.04). The most significant result was obtained for the relationship of FTND score to SNP rs12718541 (AA families: P=0.002; EA families: P=0.03; all families: P=0.0002) which is in the same intron as the splice site for a neuronal isoform of human DDC lacking exons 10–15. Haplotype analysis did not reveal any SNP combination with stronger evidence for association than rs12718541 alone. Although sequence analysis suggests that rs12718541 may be an intronic splicing enhancer, further studies are needed to determine whether a direct link exists between an alternatively spliced form of DDC and predisposition to ND. These findings confirm a previous report of association of DDC with ND, localize the causative variants to the 3' end of the coding region and extend the association to multiple population groups.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur Respir JHome page
M. Quaak, C. P. van Schayck, A. M. Knaapen, and F. J. van Schooten
Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases?
Eur. Respir. J., March 1, 2009; 33(3): 468 - 480.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
X. Chen, V. S. Williamson, S.-S. An, J. M. Hettema, S. H. Aggen, M. C. Neale, and K. S. Kendler
Cannabinoid Receptor 1 Gene Association With Nicotine Dependence
Arch Gen Psychiatry, July 1, 2008; 65(7): 816 - 823.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.